TERN

Terns Pharmaceuticals, Inc.NASDAQHealthcare

$52.72-0.13%ClosedMarket Cap: $4.75B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-31	Truist Securities	—	Hold	—
2026-03-30	Barclays	—	Equal Weight	—
2026-03-26	TD Cowen	—	Hold	—
2026-03-26	Citizens	—	Market Perform	—
2026-03-25	HC Wainwright & Co.	—	Neutral	—
2025-12-11	Citizens	—	Market Outperform	—
2025-12-09	Barclays	—	Overweight	—
2025-12-09	Truist Securities	—	Buy	—
2025-12-09	Mizuho	—	Outperform	—
2025-12-09	BMO Capital	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-1.16	$960.0K	4
Fri Dec 31	$-1.42	$5.8M	6
Sun Dec 31	$-1.73	$7.9M	5
Mon Dec 31	$-1.69	$44.6M	1